Mukka Proteins Ltd - 544135 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Mukka Proteins will conduct a postal ballot to approve a preferential issue of 2 crore convertible warrants. This capital raise of ₹47 crores at ₹23.50 per warrant will support working capital and business expansion from non-promoter allottees.
Jun 12 2026 18:57:53
Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Acquisition
Mukka Proteins Ltd. will acquire a 51% controlling stake in Delta Marine Products, a fish meal and fish oil manufacturer. The investment of up to Rs. 11.10 crore aims to expand the company's core business, optimize operations, and enhance market reach.
Jun 12 2026 17:46:50
Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Acquisition
Mukka Proteins' Board approved the acquisition of a 51% stake in Aqua Marine for up to Rs. 15 crore. This strategic investment aims to expand its core business and enhance production efficiency in the fish meal and fish oil segment.
Jun 12 2026 17:42:23
Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Preferential Issue
Mukka Proteins Ltd. approved a preferential issue of 2 crore fully convertible warrants to non-promoters. Each warrant is priced at Rs. 23.50, aggregating to Rs. 47 crore, and is convertible to equity within 18 months.
Jun 12 2026 17:26:57
Mukka Proteins Ltd - 544135 - Board Meeting Outcome for Outcome Of Board Meeting Dated 12Th June 2026.
Mukka Proteins board approved a ₹47 crore preferential allotment of 2 crore warrants at ₹23.50 each. Additionally, it approved capital contributions of ₹11.10 crore for a 51% stake in Delta Marine Products and ₹15 crore for a 51% stake in Aqua Marine, aimed at expanding core business and capacity.
Jun 12 2026 17:25:24
Mukka Proteins Ltd - 544135 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(D) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Mukka Proteins Ltd. board will convene on June 12, 2026, to discuss and approve a proposal for raising funds. The company plans to consider various instruments including preferential or rights issues, exploring capital-raising options.
Jun 09 2026 17:24:54
Mukka Proteins Ltd - 544135 - Announcement under Regulation 30 (LODR)-Credit Rating
CARE Ratings has downgraded Mukka Proteins' credit ratings for its long-term bank facilities to BBB- Negative and short-term debt to A3. This action primarily stems from a continued elongation of the company's working capital cycle and deteriorated debt coverage indicators.
May 26 2026 17:26:18
Read More